The MedTech Manufacturing Boom: How Central India is Forging the Future of Healthcare Hardware

For decades, India’s story in the global healthcare market was predominantly that of a consumer, relying heavily on imported medical devices for critical care. But a seismic shift is underway. Propelled by the dual engines of the ‘Make in India’ initiative and a post-pandemic imperative for self-reliance, the nation is rapidly transforming into a creator and manufacturer of high-quality medical technology. At the heart of this manufacturing renaissance is an unexpected contender: Central India. With its robust industrial infrastructure and strategic government support, the region, particularly the Indore-Ujjain corridor, is carving out a formidable niche in the MedTech manufacturing boom, promising a new era of innovation, investment, and entrepreneurial opportunity.

What’s Happening: The Data-Driven Surge in Domestic MedTech

The numbers paint a compelling picture of a sector on an exponential growth trajectory. India’s medical device industry, valued at approximately $12 billion in 2023-24, is projected to skyrocket to $50 billion by 2030. This isn’t speculative optimism; it’s a calculated outcome of deliberate policy-making and burgeoning market demand. The government’s Production Linked Incentive (PLI) Scheme for Medical Devices is a cornerstone of this strategy, designed to offset the cost disadvantages Indian manufacturers face compared to global competitors. With a financial outlay of ₹3,420 crores, the scheme provides a 5% incentive on incremental sales of domestically manufactured devices, targeting high-dependency areas like cancer care, radiology, imaging, and implants.

This national ambition is materializing in dedicated manufacturing clusters. One of the most promising is the Medical Device Park in Ujjain, Madhya Pradesh. This strategic initiative by the Madhya Pradesh Industrial Development Corporation (MPIDC) is transforming the state into a magnet for MedTech investment. As of early 2025, the park has already allocated land to 36 industries, attracting proposed investments of over ₹1,855 crore and aiming to generate nearly 7,000 jobs. This focused approach provides startups and established players with world-class common infrastructure facilities, drastically reducing the capital expenditure required to set up sophisticated manufacturing units.

Why It Matters: A Paradigm Shift for Founders, Investors, and Mentors

This manufacturing boom represents more than just economic growth; it’s a fundamental shift in the entrepreneurial landscape. For founders, it opens a vast new frontier beyond software and services. The healthcare hardware startups of tomorrow have an unprecedented opportunity to innovate in areas like affordable diagnostics, IoT-enabled remote monitoring devices, and AI-powered surgical tools. This move from code to physical products builds tangible assets and creates a defensible moat against global competition.

For investors, the MedTech manufacturing sector offers a compelling proposition of long-term, sustainable growth backed by real-world assets and government support. Unlike the often-volatile world of pure-play tech, investing in healthcare hardware is a bet on India’s core demographic and economic fundamentals: a growing middle class, increasing health awareness, and expanding insurance coverage. The success of the Ujjain Medical Device Park demonstrates a de-risked investment environment where infrastructure and policy are aligned for success.

For mentors and ecosystem enablers like TiE, the challenge and opportunity lie in cultivating a new breed of entrepreneur. Building a hardware company requires a different skillset, encompassing supply chain management, regulatory navigation (with bodies like the CDSCO), quality control, and patient capital. Mentorship programs must evolve to provide this specialized guidance, connecting founders with veterans from the manufacturing and healthcare sectors.

How Startups Can Respond: An Actionable Framework

Aspiring MedTech entrepreneurs in Central India can capitalize on this wave by adopting a strategic approach. The key is to move from ideation to production by leveraging the ecosystem that is being built around them. Here is a structured framework for startups looking to enter the MedTech manufacturing space:

The Local Lens: Central India’s Unfair Advantage

Central India is uniquely positioned to lead this charge. The region isn’t starting from scratch; it’s building on a solid foundation. The Indore-Pithampur belt is already one of India’s largest manufacturing hubs, with deep expertise in precision engineering and pharmaceuticals. This existing ecosystem provides a ready-made talent pool and supply chain for aspiring MedTech companies.

The academic horsepower from institutions like IIT Indore, with its focus on cutting-edge research, and IIM Indore, which nurtures business leaders, creates a fertile ground for R&D and strategic management. Further, cities like Bhopal and Jabalpur are developing their own startup ecosystems, providing a wider network of talent and resources. The government’s vision is clear: the Ujjain Medical Device Park is not an isolated project but the nucleus of a sprawling MedTech corridor across Madhya Pradesh.

Companies like CIS, founded by our author Amit Agrawal, showcase the region’s tech prowess. The fusion of this software and AI expertise with hardware manufacturing is where the real magic will happen—creating ‘smart’ medical devices that are not just made in India, but designed for the world. This synergy is what makes the MedTech manufacturing opportunity in Central India so profound.

Takeaways: A TiE Mentoring Perspective

From a TiE mentoring standpoint, the rise of MedTech manufacturing is a call to action. We must encourage and guide entrepreneurs to think beyond the digital-only model. Here are three key actions for the ecosystem:

1. Cultivate Patient Capital: Hardware is a long game. We need to connect founders with investors who understand the longer gestation periods of manufacturing ventures and are willing to provide patient, strategic capital. TiE’s angel investment programs can play a pivotal role here.
2. Foster Cross-Industry Collaboration: The future lies at the intersection of disciplines. Through events like TiE Con MP, we can facilitate partnerships between tech startups, traditional manufacturers, and healthcare professionals from cities like Indore, Bhopal, and Gwalior.
3. Champion Regulatory Literacy: We must demystify the regulatory landscape. Workshops and mentorship sessions focused on CDSCO approvals, ISO certifications, and global quality standards are essential to help our startups compete on the world stage.

The message to entrepreneurs is clear: the infrastructure is coming up, the government is backing you, and the market is waiting. Ab mauka hai, kuch kar dikhane ka! (Now is the chance to do something remarkable!). This is the time to build, to manufacture, and to heal.

Conclusion: Assembling a Healthier Future, Made in Central India

India’s journey towards becoming a global MedTech manufacturing hub is one of the most exciting economic stories of this decade. It’s a narrative of resilience, innovation, and strategic ambition. For Central India, this is a golden opportunity to move up the value chain, from being a center for traditional manufacturing to a leader in high-tech healthcare hardware. By leveraging its industrial heritage, academic excellence, and the strategic foresight of initiatives like the Ujjain Medical Device Park, the region is not just contributing to ‘Make in India’; it is defining it. For the founders, engineers, and innovators of Indore, Bhopal, and beyond, the challenge is clear: to build the devices that will save lives, not just here, but across the globe. The assembly line for a healthier world is now open in the heart of India.